ALPHA TEKNOVA INC (TKNO) Stock News
NASDAQ:TKNO - Nasdaq - US02080L1026 - Common Stock - Currency: USD
TKNO Latest News, Press Relases and Analysis
Teknova Reports First Quarter 2025 Financial Results
First quarter 2025 total revenue was $9.8 million, up 5% from prior yearCompany introduced proprietary PluriFreeze™ cryopreservation system, in...
Teknova Reports First Quarter 2025 Financial Results
Alpha Teknova (TKNO) Traded Lower on Increased Uncertainty
Conestoga Capital Advisors, an asset management company, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equity markets started the year with a rally due to optimism about a strong economy and expectations of moderating inflation and lower interest rates. However, concerns over slowing earnings from major Technology companies, geopolitical […]
Teknova to Report First Quarter 2025 Financial Results on May 8, 2025
Teknova to Report First Quarter 2025 Financial Results on May 8, 2025
HOLLISTER, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the...
TKNO Stock Earnings: Alpha Teknova Beats EPS, Beats Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Alpha Teknova (NASDAQ:TKNO) just reported results for the second quarter of 202...
Teknova and Pluristyx Launch Proprietary PluriFreeze™ Cryopreservation System to Accelerate the Development of Cell Therapies
Innovative product line is purpose-built to streamline the manufacture of allogeneic cell therapies. Available exclusively from Teknova starting today....
Teknova and Pluristyx Launch Proprietary PluriFreeze™ Cryopreservation System to Accelerate the Development of Cell Therapies
Innovative product line is purpose-built to streamline the manufacture of allogeneic cell therapies. Available exclusively from Teknova starting today.
Teknova and Pluristyx Announce Collaboration to Streamline the Manufacture of Next-Generation Cell Therapies
Teknova to Become the Exclusive Manufacturer and Distributor of Pluristyx’s Novel PluriFreeze™ Cryopreservation System...
Teknova and Pluristyx Announce Collaboration to Streamline the Manufacture of Next-Generation Cell Therapies
Teknova to Become the Exclusive Manufacturer and Distributor of Pluristyx’s Novel PluriFreeze™ Cryopreservation System
Teknova Reports Fourth Quarter and Full Year 2024 Financial Results
Teknova Reports Fourth Quarter and Full Year 2024 Financial Results
Full year 2024 total revenue was $37.7 million, up 3% year-over-year and in line with guidanceFourth quarter 2024 total revenue was $9.3 million, up 18%...
Teknova to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
HOLLISTER, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the...
Teknova to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
Teknova Reports Third Quarter 2024 Financial Results
Third quarter 2024 total revenue was $9.6 million, up 17% over the same quarter prior yearCompany lowers 2024 total free cash outflow outlook to less than...
Teknova Reports Third Quarter 2024 Financial Results
Teknova to Report Third Quarter 2024 Financial Results on November 7, 2024
HOLLISTER, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the...
Teknova to Report Third Quarter 2024 Financial Results on November 7, 2024
TKNO Stock Earnings: Alpha Teknova Beats EPS, Beats Revenue for Q2 2024
TKNO stock results show that Alpha Teknova beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Teknova Reports Second Quarter 2024 Financial Results
Second quarter 2024 total revenue was $9.6 million, up 3% sequentiallyRaised $15.4 million of equity capital in July 2024Launched two new offerings:...
Teknova Reports Second Quarter 2024 Financial Results
Teknova Introduces Proprietary Express-Tek℠ Production Service and Expanded Manufacturing Grade Options to Expedite Novel Therapy Development
Express-TekSM Production enables customers to have their products enter production in days instead of weeks, significantly shortening turnaround time New...